Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide (Mounjaro) is not contraindicated in people with hypothyroidism, and many adults living with the condition are considered for weight management treatment. The key question is whether your thyroid function is adequately controlled and whether any medicines you take alongside Mounjaro need a second look. These are exactly the kinds of factors a prescriber weighs during clinical assessment, because Mounjaro is a prescription-only medicine and personal suitability is always a clinical decision, never a blanket rule. NHS guidance on tirzepatide sets out the conditions that require particular care — hypothyroidism itself is not listed as a contraindication, but the relationship between thyroid health, body weight and GLP-1 treatment is worth understanding clearly before you decide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Hypothyroidism means your thyroid produces too little hormone, often managed long-term with levothyroxine. It frequently contributes to weight gain and makes losing weight harder, which is exactly why many people with the condition are exploring treatments like Mounjaro in the first place. If you are wondering whether you can take Mounjaro if you have hypothyroidism, the good news is that hypothyroidism, in itself, is not a contraindication listed in the Mounjaro Summary of Product Characteristics on the eMC. What matters clinically is whether your thyroid function is well controlled at the time you start.
Uncontrolled hypothyroidism can itself cause weight gain and fatigue that may be mistaken for treatment failure, which is one reason prescribers want to see thyroid function within a reasonable range before starting any structured weight management programme. If you have not had a blood test recently, checking when your last TSH result was done takes about thirty seconds in a GP patient portal, worth doing before your consultation so you can share it.
There is also a separate, important point: Mounjaro's prescribing information does carry a precaution related to thyroid tumours, specifically a personal or family history of medullary thyroid carcinoma or MEN2. This is unrelated to autoimmune hypothyroidism (such as Hashimoto's thyroiditis) but is something your prescriber will ask about directly. Our clinical team routinely screens for this during the consultation.
Tirzepatide slows how quickly food and liquid move through the stomach. For most medicines this is a minor consideration, but levothyroxine is particularly sensitive to anything that alters gut transit or absorption. It is normally taken on an empty stomach, first thing in the morning, well before food or other medicines, and that protocol becomes more important, not less, once you add a GLP-1-based treatment to the picture.
There is currently no published data showing clinically significant levothyroxine malabsorption specifically caused by tirzepatide. The interaction is a theoretical and precautionary concern based on mechanism rather than trial evidence of harm. That said, NHS England guidance on weight management injections recommends discussing all regular medicines with the prescribing team before starting, and levothyroxine sits squarely in that conversation.
In practice, the most important step is monitoring. As your weight falls on Mounjaro, your body's requirements can shift, and the levothyroxine dose that was right at a higher weight may need adjusting. Your GP or endocrinologist should be kept in the loop, and a thyroid function check after a few months of treatment is sensible. Pages covering the broader picture of how Mounjaro can affect the thyroid go into this mechanism in more detail.
When a prescriber sees hypothyroidism on your health history, the assessment focuses on a handful of specific questions: Is your TSH currently within your target range? Are you on a stable levothyroxine dose, or has it been adjusted recently? Do you have any history of thyroid cancer, particularly medullary type, or any family history of MEN2? And are there other weight-related conditions present (high blood pressure, type 2 diabetes, sleep apnoea) that affect both your eligibility for Mounjaro and the urgency of treating your weight?
At nume (at nume) a GPhC-registered Independent Prescriber reads your answers personally. Not an algorithm, not an automated eligibility checker. If the picture suggests your thyroid management needs stabilising first, or that a closer conversation with your GP or endocrinologist is needed before starting, that is what you will hear. For broader context on how thyroid conditions and tirzepatide interact, our pages on thyroid conditions and tirzepatide and on Mounjaro and hyperthyroidism cover the adjacent situations.
Pregnancy, breastfeeding and trying to conceive are all situations where Mounjaro is not recommended, regardless of thyroid status, this applies universally. If any of these apply to you, your prescriber will discuss alternative approaches.
If you have hypothyroidism and you are considering Mounjaro, the consultation is where the individual picture gets assessed properly. It helps to have your most recent thyroid function results to hand, know your current levothyroxine dose, and be ready to describe any other conditions or medicines. Under-18s are not eligible, and everyone needs a BMI of at least 30 (or 27 with a qualifying weight-related condition) to meet the licensed criteria, details are on the weight-loss treatments page.
Cost is a common practical question. Mounjaro is a private prescription at nume, with one transparent price that covers the consultation, prescription, treatment and next-working-day delivery, no separate fees stacked on top. The Mounjaro pricing page has current figures. And if you want to understand the full range of options, the weight-loss overview sets out where Mounjaro sits alongside other approaches. Speak to our prescribers, and we will work through the specifics with you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.